Comparison of the effect of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men

American Journal of Ophthalmology

Volumn 121, Issue 4, 1996, Pages 367-371

  Dickstein, K ^a   Aarsland, T ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TIMOLOL; BACTERIAL POLYSACCHARIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EYE DROPS; GELLAN; WATER;

ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; EXERCISE; GEL; HEART RATE; HEART STROKE VOLUME; HUMAN; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; TASK PERFORMANCE; TOPICAL DRUG ADMINISTRATION; ABSORPTION; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE TEST; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ABSORPTION; ADRENERGIC BETA-ANTAGONISTS; AGED; CONJUNCTIVA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; EXERCISE; EXERCISE TEST; GELS; HEART RATE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; POLYSACCHARIDES, BACTERIAL; TIMOLOL; WATER;

EID: 0029664409     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)70432-5     Document Type: Article

References (22)

1. TJ. Zimmerman Topical ophthalmic beta-blockers: a comparative review J Ocul Pharmacol 9 1993 373 384
2. C Leier D Baker P. Weber Cardiovascular effects of ophthalmic timolol Ann Intern Med 104 1986 197 199
3. WL Nelson FT Fraunfelder JM Sills JB Arrowsmith JN. Kuritsky Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978–1985 Am J Ophthalmol 102 1986 606 611
4. T Kaila L Salminen R. Huupponen Systemic absorption of topically applied ocular timolol J Ocul Pharmacol 1 1985 79 83
5. J Laurence D Holder R Vogel RL Gross BG Haik DW Karp A double-masked, placebo-controlled evaluation of timolol in a gel vehicle J Glaucoma 2 1993 177 182
6. MB Higginbotham KG Morris RS Williams PA McHale RE Coleman FR. Cobb Relation of stroke volume during submaximal and maximal upright exercise in normal men Circ Res 58 1986 281 291
7. EE Wolfel WR Hiatt HL Brammell MR Carry SP Ringel V Travis Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning Circulation 74 1986 664 674
8. M Bevilacqua S Savonitto E Bosisio E Chebat P Bertore M Sardina Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men Am J Cardiol 63 1989 853 857
9. S Barvik K Dickstein T Aarsland H. Vik-Mo Effect of nonselective timolol on cardiopulmonary exercise performance in men after myocardial infarction Am J Cardiol 69 1992 163 168
10. K Dickstein R Hapnes T Aarsland K Kristianson L. Viksmoen A comparison of timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers Acta Ophthalmol (Copenh) 66 1988 463 466
11. WJ Doyle PA Weber RH. Meeks Effect of topical timolol maleate on exercise performance Arch Ophthalmol 102 1984 1517 1518
12. T Kaila R Huupponen S Karhuvaara P Havula M Scheinin E Iisalo Beta-blocking effects of timolol at low plasma concentrations Clin Pharmacol Ther 49 1991 53 58
13. TJ Zimmerman BJ Leader DS. Golob Potential side effects of timolol therapy in the treatment of glaucoma Ann Ophthalmol 13 1981 683 689
14. JM Atkins BR Pugh Jr R. Timewell Cardiovascular effects of topical beta-blockers during exercise Am J Ophthalmol 99 1985 173 175
15. A Rozier C Mazuel J Grove B. Plazonnet Gelrite: a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles: effect on bioavailability of timolol Int J Pharm 57 1989 163 168
16. A. Shedden Timolol maleate in gel-forming solution: a novel formulation of timolol maleate Chibret J Ophthalmol 10 1994 32 36
17. AH Shedden JK Laurence RW Tipping R Vogel MB Abelson RC Allen Multiclinic, double-masked study of 0.5% timoptic-XE (TXE) once daily versus 0.5% timoptic (TS) twice daily Ophthalmology 100 9A 1993 111 112
18. N Levy C. Alsbury Evaluation of timolol in gellan gum: a new vehicle to extend its duration of action Ann Ophthalmol 26 1994 166 169
19. MS Passo EA Palmer EM. Van Buskirk Plasma timolol in glaucoma patients Ophthalmology 91 1984 1361 1363
20. ML Vuori T Ali-Melkkila T Kaila E Iisalo KM. Saari Plasma and aqueous humour concentrations and systemic effects of topical betaxolol and timolol in man Acta Ophthalmol (Copenh) 71 1993 201 206
21. G Alvan B Calissendorff P Seideman K Widmark G. Widmark Absorption of ocular timolol Clin Pharmacokinet 5 1980 95 100
22. N Maren G Alvan BM Calissendorff K Haglund P. Seideman Additive intraocular pressure reducing effect of topical timolol during systemic beta-blockade Acta Ophthalmol (Copenh) 60 1982 16 23